{
  "id": "5e2dac4efbd6abf43b00000f",
  "type": "yesno",
  "question": "Has istadefylline been considered as a treatment for Parkinson's disease?",
  "ideal_answer": "Yes, istradefylline is a new drug developed for the treatment of Parkinson's disease.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30232916"
  ],
  "snippets": [
    {
      "text": "Istradefylline (ISD) is a new drug developed for the treatment of Parkinson's disease (PD). It is an adenosine receptor A2A antagonists that will represent an important option for patients with advanced PD where it has been demonstrated efficacy in decreasing daily OFF time and is well tolerated. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30232916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The objective of this review is to summarize evidences emerged from clinical studies that have demonstrated the efficacy of ISD in advanced parkinsonian patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30232916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " ISD might represent an alternative option for patients with advanced PD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30232916",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}